Old mice lost some gut bacteria and fought flu late; a gut-made acid helped aging lung cells in a dish

Flu is much more dangerous for older people. Part of the reason is that the immune system ages. A research team at Jena University Hospital in Germany looked at a less obvious player: the bacteria in the gut. In mice, they found that age changed which gut bacteria were present and what those bacteria could make. Then, in human lung cells in a dish, they tested one of those products, acetate, and found that it slowed the flu virus. The work combines a mouse study with cell experiments; nothing here has been tested in people.

Gut bacteria break down dietary fibre and release short-chain fatty acids, small molecules such as acetate, propionate and butyrate. These can pass into the blood and influence the immune system far from the gut, including in the lungs. Since lung infections can also change the gut, researchers call this two-way link the “gut–lung axis.” The team's earlier work had suggested that acetate can make it harder for the flu virus to get into cells, and that senescent cells (cells that have permanently stopped dividing, which build up with age) are especially easy for flu to infect.

What they did

The team infected young mice (8 to 12 weeks old) and old mice (18 to 24 months) with a dose of a mouse-adapted flu virus meant to make them ill but not to kill them. Others got a mock treatment for comparison. In total there were 96 female mice. Groups were examined at day 4 (acute illness), day 8 and day 21 (recovery). The team measured weight, illness scores, virus levels in fluid washed out of the lungs, inflammatory signals, and which genes were active in lung tissue. They also sequenced all the bacterial DNA in droppings collected before infection and on days 4 and 21.

For the second part they used fibroblasts, the cells that make connective tissue, from human lungs. They turned some into senescent cells with doxorubicin, a chemotherapy drug that damages DNA, and compared them with resting cells that had simply stopped dividing for a while. Some cells were bathed in acetate for a day before being infected with a standard laboratory flu strain.

What they found

• Old mice already looked different before infection. Their blood carried more inflammatory signals, and their gut held fewer of two common bacteria, Faecalibaculum rodentium and Akkermansia muciniphila, and more Clostridium.
• Flu ran a different course with age. Young mice showed more signs of illness early on. Old mice switched on several antiviral interferon genes less strongly (an early-warning system against viruses) on day 4, then had more virus and more inflammatory signals in their lungs on day 8. Their weight was still below the starting level on day 21.
• The infection shook up the gut in both ages, more so in old mice, and by day 21 the gut had partly drifted back toward its earlier state. Gene counts suggested that the bacteria of old mice had less capacity for a step that produces acetate.
• In the dish, acetate helped the aging cells. Senescent fibroblasts made markedly more virus than resting ones. Acetate given beforehand cut virus production and inflammatory signals in the senescent cells, without harming them. Senescent cells carried more of FFAR2 and FFAR3, two receptors on the cell surface that sense short-chain fatty acids.
• Acetate also changed gene packaging. DNA is wound around proteins called histones, and chemical tags called acetyl groups on them help decide which genes are read. Flu lowered these tags on one histone (H3) in senescent cells; acetate brought them back up.

What to keep in mind

• The two halves are linked by a hypothesis, not proven cause and effect. The authors call the acetate idea a hypothesis that the mouse data generated. Acetate levels themselves were not measured in the mice; the gut finding is based on bacterial genes. The authors say direct measurement of these acids and checks in older people's lung tissue and in patients are still needed.
• The mice were all female, and the study was neither randomized nor blinded. Several infected mice reached humane endpoints (they were put down because they were too sick) before day 21: 6 of 10 young and 3 of 10 old in the day-21 groups.
• The cell model is simplified. It used one human cell line, aged artificially with a chemotherapy drug, and fibroblasts rather than the lining cells that flu mainly infects. The cell experiments used a different virus strain from the mouse work, and each test was repeated only five or six times.
• No one gave acetate to the mice. Whether raising acetate in a living animal, let alone a person, would change the course of flu was not tested. The study does not support taking vinegar, probiotics or any supplement.

Why it matters

Older people are hit hardest by flu, so it matters to understand why. This study adds to the idea that the gut and its bacteria are part of how well the lungs fight off viruses with age, and it points to acetate as one possible messenger. The authors see acetate-related pathways as a target for future treatments that strengthen the body's own defences. For now, it is a lead for further animal work and studies in people, not a finding to act on.